Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Perkins

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
International Journal of Pediatric Otorhinolaryngology|September 19, 2021
Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformationsJuliana Bonilla-Velez, Kathryn B Whitlock, Sheila Ganti, et al.
International Journal of Pediatric Otorhinolaryngology|December 2, 2022
Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infantsClare M Richardson, Jonathan N Perkins, Kaitlyn Zenner, et al.
HGG Advances|April 4, 2022
Somatic activating <i>BRAF</i> variants cause isolated lymphatic malformationsKaitlyn Zenner, Dana M Jensen, Victoria Dmyterko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 6, 2022
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowthTara L Wenger, Sheila Ganti, Catherine Bull, et al.
The Journal of Investigative Dermatology|April 23, 2023
Upregulated MicroRNA-21 Drives the Proliferation of Lymphatic Malformation Endothelial Cells by Inhibiting PDCD4Ravi W Sun, Haihong Zhang, Syed J Mehdi, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 23, 2008
Multicenter interrater and intrarater reliability in the endoscopic evaluation of velopharyngeal insufficiencyKathleen C Y Sie, Jacqueline R Starr, David C Bloom, et al.
Human Molecular Genetics|June 16, 2018
Pathogenic variant in EPHB4 results in central conducting lymphatic anomalyDong Li, Tara L Wenger, Christoph Seiler, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 13, 2021
Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin SequenceAustin S Lam, Michael D Bindschadler, Kelly N Evans, et al.
Nature Medicine|July 3, 2019
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Michael E March, Alvaro Gutierrez-Uzquiza, et al.
The Journal of Pediatrics|February 15, 2015
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CAValerie L Luks, Nolan Kamitaki, Matthew P Vivero, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
International Journal of Pediatric Otorhinolaryngology|September 19, 2021
Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformationsJuliana Bonilla-Velez, Kathryn B Whitlock, Sheila Ganti, et al.
International Journal of Pediatric Otorhinolaryngology|December 2, 2022
Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infantsClare M Richardson, Jonathan N Perkins, Kaitlyn Zenner, et al.
HGG Advances|April 4, 2022
Somatic activating <i>BRAF</i> variants cause isolated lymphatic malformationsKaitlyn Zenner, Dana M Jensen, Victoria Dmyterko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 6, 2022
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowthTara L Wenger, Sheila Ganti, Catherine Bull, et al.
The Journal of Investigative Dermatology|April 23, 2023
Upregulated MicroRNA-21 Drives the Proliferation of Lymphatic Malformation Endothelial Cells by Inhibiting PDCD4Ravi W Sun, Haihong Zhang, Syed J Mehdi, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 23, 2008
Multicenter interrater and intrarater reliability in the endoscopic evaluation of velopharyngeal insufficiencyKathleen C Y Sie, Jacqueline R Starr, David C Bloom, et al.
Human Molecular Genetics|June 16, 2018
Pathogenic variant in EPHB4 results in central conducting lymphatic anomalyDong Li, Tara L Wenger, Christoph Seiler, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 13, 2021
Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin SequenceAustin S Lam, Michael D Bindschadler, Kelly N Evans, et al.
Nature Medicine|July 3, 2019
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Michael E March, Alvaro Gutierrez-Uzquiza, et al.
The Journal of Pediatrics|February 15, 2015
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CAValerie L Luks, Nolan Kamitaki, Matthew P Vivero, et al.
Pageof 12